Navigation Links
Cell Signaling Technology Releases Four Monoclonal Antibodies for Immunometabolism and Tumor Immunology Research

Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, released four new monoclonal antibodies relevant to the rapidly growing fields of immunometabolism and tumor immunology.

CST has released Arginase-1 (D4E3M™ XP® #93668, LAG3 (D2G4O™) #15372, ICOS (D1K2T™) (IHC Specific) #89601, and PD-L1 (D5V3B) (Mouse Specific; IHC Specific) #64988 rabbit monoclonal antibodies (mAbs). These rabbit mAbs complement CST’s expanding portfolio of products that support tumor immunology research, including antibodies detecting the PD-1/PD-L1 family of immune checkpoint proteins, as well as metabolic targets, such as IDO, that have been proposed to promote immune suppression within the tumor microenvironment. Introduction of ICOS rabbit mAb also highlights the growing list of antibodies that detect co-stimulatory molecules, such as CD40L, OX40, and OX40L that research studies have demonstrated to have a role in augmenting anti-tumor immune responses.

All four newly released antibodies are recommended for immunohistochemistry (IHC), an application that helps visualize protein expression in the context of preserved tissue architecture, which is key to the translational research community interested in the study of tumor immunology.

Notably, the newly released Arginase-1 rabbit mAb exhibits mouse as well as human reactivity, while the new rabbit mAb targeting PD-L1 demonstrates exclusive specificity to mouse tissue, a critical feature to enable pre-clinical studies, typically carried out in murine models of disease.

CST’s recent announcement introducing the company’s capabilities to produce stringently characterized GMP-grade recombinant rabbit monoclonal antibodies further reinforces the impact that Arginase-1, LAG3, ICOS, PD-L1, and other related antibodies from CST could have on fostering the transition from basic to translational research.

“With the release of these antibodies, we are continuing to build on a rich repertoire of products that are highly enabling to the research community interested in tumor immunology. Our goal is to help scientists understand how tumors interact with the cells of the immune system and how ancillary immunosuppressive factors promote tumor growth. We hope that this understanding may help inform better treatment strategies for many cancers,” said Michael J. Comb, CEO of CST.

About CST
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high quality research tools to the biomedical research community. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.

D4E3M™ D2G4O™ D1K2T, XP®, Cell Signaling Technology®, and CST™ are trademarks of Cell Signaling Technology, Inc.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. Review of a New SkinCare Gel that uses Redox Signaling Technology
2. CEDs Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector
3. Study Reports Significant Reduction in Stress via Electrical Neurosignaling
4. Publication in Nature Demonstrates Physiocrine Genetic Mutation Disrupts A Key Signaling Pathway in Neuronal Biology
5. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
6. Verdad Media’s Unique MANIS Technology Means Better Reputation Management Results for Clients
7. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
8. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
9. Annual Conference about Technology Solutions for People with Disabilities Announces Program
10. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
11. GIN Introduces Advanced Robotics and Dispensing Technology at BVS La Jolla Biotech Day
Post Your Comments:
(Date:5/31/2019)... ... May 30, 2019 , ... A ... an efficient delivery system for the sustained release of human placental stem cell ... system was able to deliver CM into the injured kidney, where it helped ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the magic ... beverage products rely on these ingredients to create stable quality food that can ... paradigm shift triggers food formulators to seek out alternatives for starches, gums and ...
(Date:5/7/2019)... Columbia (PRWEB) , ... May 06, 2019 , ... ... a go-to resource for the growing number of repositories being asked to store ... are grateful to the team of contributors who are world leaders, who have ...
(Date:5/2/2019)... ... 30, 2019 , ... The centuries old practice of brewing beer thrives today ... breweries, and even home brewing clubs scattered across the nation. , But proper ... mastered can produce a superb product. Students at South Dakota School of Mines ...
Breaking Biology Technology:
(Date:5/31/2019)... ... May 30, 2019 , ... Join ... live webinar on Wednesday, June 19, 2019 at 1pm EDT where ... review teams, data management teams and contract research organizations (CROs) can improve collaboration, ...
(Date:5/23/2019)... , ... May 23, 2019 , ... Federal Publications Seminars, ... years, is pleased to announce the release of FPSOnline 2.0, an updated version of ... premier weeklong conferences , La Jolla Government Contracts Week, were given a “sneak ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend encompassing culinary travel, cultural ... several years. And according to a recent report by Skift, a media company ... more and more travelers are wanting their journeys to be authentic and unique, and ...
Breaking Biology News(10 mins):